Andersson, N. G., Labarque, V., Kartal-Kaess, M., Pinto, F., Mikkelsen, T. S., Ljung, R., & Group, P. S. (2023). Factor VIII genotype and the risk of developing high-responding or low-responding inhibitors in severe hemophilia A. Haematologica, 109(4), . https://doi.org/10.3324/haematol.2023.284095
Chicago Style (17th ed.) CitationAndersson, Nadine G., Veerle Labarque, Mutlu Kartal-Kaess, Fernando Pinto, Torben Stamm Mikkelsen, Rolf Ljung, and PedNet Study Group. "Factor VIII Genotype and the Risk of Developing High-responding or Low-responding Inhibitors in Severe Hemophilia A." Haematologica 109, no. 4 (2023). https://doi.org/10.3324/haematol.2023.284095.
MLA (9th ed.) CitationAndersson, Nadine G., et al. "Factor VIII Genotype and the Risk of Developing High-responding or Low-responding Inhibitors in Severe Hemophilia A." Haematologica, vol. 109, no. 4, 2023, https://doi.org/10.3324/haematol.2023.284095.